|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
785,947,000 |
Market
Cap: |
109.95(M) |
Last
Volume: |
1,046,562 |
Avg
Vol: |
834,362 |
52
Week Range: |
$0.0303 - $0.205 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Elite Pharmaceuticals is a pharmaceutical company. Co. owns, licenses or contracts manufacture various products that are being sold commercially, including: bariatric products, which include Phentermine HCl 37.5mg tablets and Phendimetrazine Tartrate 35mg tablets; pain products, which include Naltrexone HCl 50mg tablets and Oxycodone HCl Immediate Release five mg, 10mg, 15mg, 20mg and 30mg tablets; cardiovascular product, which includes Isradipine 2.5mg and five mg capsules; antidepressant product, which includes Trimipramine Maleate Immediate Release 25mg, 50mg and 100mg capsules; and muscle relaxant product, which includes Dantrolene Sodium Capsules 25mg, 50mg and 100mg.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hakim Nasrat A |
CEO, President |
|
2024-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
49,534,368 |
216,649,250 |
|
- |
|
Hakim Nasrat A |
CEO, President |
|
2023-12-29 |
4 |
A |
$0.07 |
$153,397 |
I/I |
2,223,147 |
2,223,147 |
|
- |
|
Caskey Davis S |
Director |
|
2023-11-22 |
4 |
A |
$0.04 |
$19,989 |
D/D |
547,657 |
2,049,436 |
|
- |
|
Dash Barry H |
Director |
|
2023-11-22 |
4 |
A |
$0.04 |
$19,989 |
D/D |
547,657 |
3,235,555 |
|
- |
|
Whitnell Jeffrey A |
Director |
|
2023-11-22 |
4 |
A |
$0.04 |
$19,989 |
D/D |
547,657 |
3,187,020 |
|
- |
|
Dash Barry H |
Director |
|
2022-08-28 |
4 |
A |
$0.04 |
$19,990 |
D/D |
459,536 |
2,687,898 |
|
- |
|
Whitnell Jeffrey A |
Director |
|
2022-08-28 |
4 |
A |
$0.04 |
$19,990 |
D/D |
459,536 |
2,639,363 |
|
- |
|
Caskey Davis S |
Director |
|
2022-08-28 |
4 |
A |
$0.04 |
$19,990 |
D/D |
459,536 |
1,501,779 |
|
- |
|
Caskey Davis S |
Director |
|
2021-06-30 |
4 |
A |
$0.07 |
$20,010 |
D/D |
295,570 |
1,042,243 |
|
- |
|
Whitnell Jeffrey A |
Director |
|
2021-06-30 |
4 |
A |
$0.07 |
$20,010 |
D/D |
295,570 |
2,179,827 |
|
- |
|
Dash Barry H |
Director |
|
2021-06-30 |
4 |
A |
$0.07 |
$20,010 |
D/D |
295,570 |
2,228,182 |
|
- |
|
Hakim Nasrat A |
CEO & President |
|
2020-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
158,017,321 |
167,114,882 |
|
- |
|
Caskey Davis S |
Director |
|
2020-08-20 |
4 |
A |
$0.09 |
$45,012 |
D/D |
516,781 |
746,673 |
|
- |
|
Whitnell Jeffrey A |
Director |
|
2020-08-20 |
4 |
A |
$0.09 |
$45,012 |
D/D |
516,781 |
1,884,257 |
|
- |
|
Dash Barry H |
Director |
|
2020-08-20 |
4 |
A |
$0.09 |
$45,012 |
D/D |
516,781 |
1,932,612 |
|
- |
|
Plassche Douglas |
SVP Operations |
|
2020-08-20 |
4 |
A |
$0.09 |
$6,284 |
D/D |
71,739 |
1,133,932 |
|
- |
|
Plassche Douglas |
SVP of Operations |
|
2020-06-30 |
4 |
A |
$0.09 |
$49,990 |
D/D |
574,597 |
1,062,193 |
|
- |
|
Whitnell Jeffrey A |
Director |
|
2018-02-26 |
4 |
A |
$0.12 |
$19,994 |
D/D |
161,374 |
1,367,476 |
|
- |
|
Dash Barry H |
Director |
|
2018-02-26 |
4 |
A |
$0.12 |
$19,994 |
D/D |
161,374 |
1,415,831 |
|
- |
|
Caskey Davis S |
Director |
|
2018-02-26 |
4 |
A |
$0.12 |
$19,994 |
D/D |
161,374 |
229,892 |
|
- |
|
Plassche Douglas |
SVP of Operations |
|
2018-02-26 |
4 |
A |
$0.12 |
$24,993 |
D/D |
201,717 |
487,596 |
|
- |
|
Pfeifer Eugene M |
Director |
|
2018-02-26 |
4 |
A |
$0.12 |
$19,994 |
D/D |
161,374 |
233,414 |
|
- |
|
Ward Carter Julian |
CFO, Sec., Treas. |
|
2018-02-26 |
4 |
A |
$0.12 |
$29,991 |
D/D |
242,060 |
2,127,364 |
|
- |
|
Hakim Nasrat A |
CEO & President |
|
2017-04-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(158,017,321) |
9,097,561 |
|
- |
|
Caskey Davis S |
Director |
|
2017-02-23 |
4 |
A |
$0.20 |
$13,443 |
D/D |
68,518 |
68,518 |
|
- |
|
86 Records found
|
|
Page 1 of 4 |
|
|